Medical Care
US Healthcare Costs for Older Adults: Trailing Developed Democracies
2024-12-04
Older Americans often find themselves facing significant healthcare challenges. A recent report by the Commonwealth Fund has shed light on these issues, revealing that they spend more on healthcare compared to their peers in 10 other developed democracies.

Uncovering the Healthcare Disparities Among Older Americans

Medicare's Cost-Sharing Requirements

The new report emphasizes how Medicare, the public health insurance program for those aged 65 and above and the disabled, has substantial cost-sharing obligations. These include co-pays, deductibles, and no cap on out-of-pocket expenses. As a result, even though nearly all older adults in the US are covered by Medicare, there are areas where the program can be improved. In some countries, almost no older adults skip or delay care due to cost.

For example, traditional Medicare lacks many essential benefits that older Americans and disabled people need, such as vision, dental, and hearing care, as well as long-term or home care. While Medicare Advantage offers some of these benefits, it has faced criticism for unfairly denying care and being overly costly. It has even been the target of federal fraud investigations.

Conservatives have proposed further privatization of Medicare by implementing "default enrollment" in Medicare Advantage. The president-elect, Donald Trump, promised "no cuts" to the program in the official Republican platform, but the details remain unclear.

Medicare Programs and Their Implications

Medicare is available through two main programs - traditional Medicare, also known as "fee-for-service", and Medicare Advantage managed by private insurers. Each program has its own set of advantages and disadvantages. Traditional Medicare may lack certain benefits, but it provides more flexibility. Medicare Advantage, on the other hand, offers additional benefits but has faced criticism for its practices.

For instance, in terms of healthcare access and outcomes, the US has the most expensive health system in the world. Despite the high prices, it performs poorly on metrics such as health equity, accessibility, and outcomes. Rising costs are forcing many older Americans to pay more out of pocket, which leads to delayed care, poorer health, and higher long-term spending.

Data from the Commonwealth Fund's international survey of older adults shows that almost a quarter of older adults in the US spent $2,000 or more on healthcare in the past year, compared to less than 5% in France and the Netherlands. Similarly, older adults in the US reported the highest levels of cost barriers to care, although less than 10% actually encountered such barriers. In contrast, one in five older adults in the US, Australia, and Canada reported skipping needed dental care, while in the Netherlands and Germany, the rate was less than 5%. Less than 5% of adults in all countries reported skipping needed mental health care due to cost.

Comparing Healthcare Across 10 Countries

The Commonwealth report used data from its international survey to compare health benefits across 10 countries: Australia, Canada, France, Germany, the Netherlands, New Zealand, Sweden, Switzerland, the United Kingdom, and the United States. This comparison highlights the differences in healthcare systems and their impact on older adults.

It becomes evident that different countries have different approaches to healthcare for older adults. Some countries have managed to provide better access and affordability, while others still face challenges. Understanding these differences can help inform policy decisions and improve healthcare for older Americans.

Overall, this study emphasizes the importance of Medicare for older adults in the US but also highlights the need to address the challenge of affording needed care. By examining these issues in detail, we can work towards finding solutions to improve the healthcare situation for older Americans.

UnitedHealthcare CEO Killed in Targeted Shooting Outside NYC Hotel
2024-12-04
UnitedHealthcare CEO Brian Thompson met a tragic end on Wednesday morning. The incident occurred outside a Manhattan hotel where the health insurer was hosting an investor conference. This brazen act has sent shockwaves through the business and healthcare communities.

"The Targeted Killing of UnitedHealthcare's Leader - A Devastating Loss"

Details of the Shooting

At around 6:45 a.m., Thompson was set to speak at the investor meeting when a shooter opened fire. The shooter fled on foot and later took an e-bike into Central Park. Despite the efforts of the New York Police Department, the shooter remains at large as of late morning, and no arrests have been made. Although officials suspect the attack was targeted, the motive remains unknown.

Thompson was rushed to a hospital but unfortunately, his life could not be saved. The Hilton, where the incident took place, is in a bustling area of Manhattan, close to tourist sites like the Museum of Modern Art and Rockefeller Center. On a weekday morning, it is often filled with tourists and office workers.

UnitedHealthcare's Importance

UnitedHealthcare is the insurance arm of the healthcare giant UnitedHealth Group Inc. Based in Minnetonka, Minnesota, the company was scheduled to have its annual meeting with investors in New York City to update Wall Street on its future direction and expectations. An early end to the conference was announced to attendees on Wednesday morning.

It is the largest provider of Medicare Advantage plans in the U.S. and manages health insurance coverage for employers and state-and federally funded Medicaid programs. The company has a significant presence and impact in the healthcare industry.

Response and Condolences

New York City officials, including Police Commissioner Jessica Tisch and Governor Kathy Hochul, have expressed their shock and condemnation. Mayor Eric Adams stated that police are reviewing evidence from the scene, including video, in an effort to apprehend the shooter.

Minnesota Gov. Tim Walz also tweeted, sending prayers to Brian's family and the UnitedHealthcare team. He described the news as horrifying and a terrible loss for the Minnesota business and healthcare community.

Impact on the Area

The block where the shooting took place was cordoned off with police tape, and a large number of police officers were present at the scene. Many security cameras in the vicinity may provide valuable clues for the investigation.

Thompson had served as CEO for over three years and had been with the company since 2004. His leadership and contributions will be remembered in the company and the industry.

See More
FDA Announces Final Guidance on AI Medical Device Life Cycle
2024-12-04
The U.S. Food and Drug Administration has taken a significant step by making public its final guidance regarding AI medical devices. This document, titled "Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions," aims to pave the way for the safe and effective development of such devices. Tuesday's statement from the agency highlights its forward-thinking approach in this regard.

Revolutionize Medical Care with FDA's AI Guidance

Details of the Guidance

The guidance offers crucial recommendations on the information that should be included in a marketing submission for a device with one or more AI-enabled device software functions. FDA emphasizes that for modifications to these AI-DSFs, which are inevitable over time, a completely new market submission is not required. As stated in the final guidance posted in the Federal Register, "Because modifications that are specified and implemented in accordance with an authorized PCCP were reviewed and authorized through the marketing submission containing the PCCP, the modifications can be implemented to the AI-DSF without triggering the need for a new marketing submission." Instead, the agency will focus on the aspects of the device that have undergone significant modifications and suggests submitting documents with tracked changes.This approach is set to streamline the regulatory process and ensure the continuous improvement of AI medical devices. The agency will host a webinar on January 14, 2025, to provide industry and others with more insights into the final guidance.

Impact of the Larger Trend

The FDA has made it clear that while it is committed to expediting the deployment of new devices, it will maintain a science-based approach to the requirements for medical devices powered by AI and ML. In its March announcement opening a public comment period, Brendan O’Leary, deputy director of the Digital Health Center of Excellence in the FDA’s Center for Devices and Radiological Health, discussed how the agency considered various factors during the ongoing development, validation, implementation, and monitoring of AI/ML-enabled devices. These factors include performance concerning race, ethnicity, disease severity, gender, age, and geographical considerations.This comprehensive approach shows the FDA's dedication to ensuring the fairness and effectiveness of AI in medical devices across different demographics and regions.

Application of the Guidance

The recommendations in this guidance apply not only to standalone AI-enabled devices but also to the device constituent part of device-led combination products. These products are reviewed through various pathways such as the 510(k), De Novo, and PMA. FDA's longstanding commitment to developing and applying innovative approaches to the regulation of AI-enabled devices is further reinforced by this guidance. It provides a clear framework for developers to follow, ensuring that AI medical devices meet the necessary safety and efficacy standards.This guidance is a crucial step in the evolution of AI in healthcare, enabling developers to navigate the regulatory landscape more effectively and bring innovative products to market. It also helps to build trust among patients and healthcare providers by ensuring that AI-powered devices are rigorously evaluated and regulated.
See More